日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metabolic landscape of disseminated cancer dormancy

播散性癌症休眠的代谢图谱

Drapela, Stanislav; Garcia, Bruna M; Gomes, Ana P; Correia, Ana Luísa

Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation.

靶向抑制休眠型乳腺癌细胞对 PIK3C3-mTORC1 信号的依赖性可抑制转移的发生

Elkholi Islam E, Robert Amélie, Malouf Camille, Wu Joshua L, Kuasne Hellen, Drapela Stanislav, Macleod Graham, Hébert Steven, Pacis Alain, Calderon Virginie, Kleinman Claudia L, Gomes Ana P, Alvarez James V, Aguirre-Ghiso Julio A, Park Morag, Angers Stéphane, Côté Jean-François

Methylmalonic acid induces metabolic abnormalities and exhaustion in CD8(+) T cells to suppress anti-tumor immunity

甲基丙二酸诱导CD8(+) T细胞代谢异常和耗竭,从而抑制抗肿瘤免疫。

Tejero, Joanne D; Hesterberg, Rebecca S; Drapela, Stanislav; Ilter, Didem; Raizada, Devesh; Lazure, Felicia; Kashfi, Hossein; Liu, Min; Silvane, Leonardo; Avram, Dorina; Fernández-García, Juan; Asara, John M; Fendt, Sarah-Maria; Cleveland, John L; Gomes, Ana P

Protocol for the utilization of murine interstitial fluid extract to model breast cancer in the context of old age in vitro

利用小鼠间质液提取物在体外模拟老年乳腺癌的方案

Drapela, Stanislav; Rad, Rojan Chimeh; Ilter, Didem; Gomes, Ana P

Collagen hydroxylation couples NAD+/NADH dynamics to tumor dormancy and reactivation.

胶原蛋白羟基化将 NAD+/NADH 动态与肿瘤休眠和再激活联系起来

De Martino Daniela, Zapatería Begoña, Dunne Jaclyn B, Drapela Stanislav, Matteson Kailie, Oruko Duncan, Humphrey Taylor, Jonhston Tyler, Varghese Betsy Ann, Riggio Alessandra I, Tiwary Kanishka, Bresnahan Erin, Barra Jonathan, Sowa Allison, Jenssen William, Sidoli Simone, Welm Alana L, Barroso Margarida, Stallaert Wayne, Gomes Ana P, Angel Peggi M, Arias Esperanza, Bravo-Cordero Jose Javier

Metabolic reprogramming: a bridge between aging and tumorigenesis

代谢重编程:衰老与肿瘤发生之间的桥梁

Drapela, Stanislav; Ilter, Didem; Gomes, Ana P

Metabolic requirements of the metastatic cascade

转移级联的代谢需求

Drapela, Stanislav; Gomes, Ana P

Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells

新型CHK1抑制剂MU380在TP53突变型慢性淋巴细胞白血病细胞中表现出显著的单药活性。

Boudny, Miroslav; Zemanova, Jana; Khirsariya, Prashant; Borsky, Marek; Verner, Jan; Cerna, Jana; Oltova, Alexandra; Seda, Vaclav; Mraz, Marek; Jaros, Josef; Jaskova, Zuzana; Spunarova, Michaela; Brychtova, Yvona; Soucek, Karel; Drapela, Stanislav; Kasparkova, Marie; Mayer, Jiri; Paruch, Kamil; Trbusek, Martin